Assessing response to anti-thymocyte globulin therapy in chronic lung allograft dysfunction
<title>Extract</title> Treatment response to r-ATLG in CLAD is not uniform, but is most evident in patients with rapidly progressive disease, highlighting the importance of trajectory-based patient selection.
Authors
- Saskia Bos (ORCID: https://orcid.org/0000-0002-5336-5914)
- Robin Vos (ORCID: https://orcid.org/0000-0002-3468-9251)
- Andrea Zajacová (ORCID: https://orcid.org/0000-0002-9691-2500)
- Marta Zapata‐Ortega (ORCID: https://orcid.org/0000-0003-0379-358X)
- B M Vanaudenaerde
- Lara Verbeylen
- Pedro Argos-Velez
Institutions
- Marqués de Valdecilla University Hospital (ES)
- KU Leuven (BE)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2026-06-25
- DOI
- https://doi.org/10.1183/23120541.00692-2026
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fonds Wetenschappelijk Onderzoek